GlassScriptPhysician profile
Lisa R Hollar
NPI 1457347452
$1,744.13
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $32.74 · 2021: $265 · 2022: $354 · 2023: $394 · 2024: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $718.46 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $151.48 | 2021-2023 | |
| Coopersurgical, INC. | $103.13 | 2019-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $102.81 | 2022-2023 | |
| Organon LLC | $100.69 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $75.38 | 2022 | |
| Merck Sharp & Dohme LLC | $65.71 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $54.39 | 2019-2020 | |
| Myriad Women'S Health, INC. | $53.31 | 2023 | |
| Hologic Sales and Service, LLC | $40.40 | 2019-2024 | Aptima |
| Astellas Pharma US INC | $38.67 | 2024 | Veozah |
| Optumhealth Care Solutions, LLC | $34.02 | 2023-2024 | Vivify Health Care Team Portal, Eitan Medical, Vivify Health Care Team Portal 001 |
| Avion Pharmaceuticals | $28.91 | 2022-2023 | Balcoltra |
| Biogen, INC. | $28.66 | 2024 | Zurzuvae |
| Exeltis, USA INC. | $27.99 | 2022-2023 | Slynd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $22.48 | 2023 | Myfembree |
| Allergan, INC. | $18.92 | 2019 | |
| Pfizer INC. | $18.59 | 2021 | |
| Boston Scientific Corporation | $16.91 | 2024 | |
| Minerva Surgical, INC | $16.77 | 2019 | |
| Evofem Biosciences, INC. | $15.53 | 2021 | |
| Covidien LP | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hollar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.